Literature DB >> 6854456

Effect of gestational age on ductus arteriosus response to circulating prostaglandin E2.

R I Clyman, F Mauray, C Roman, M A Heymann, B Payne.   

Abstract

Premature newborn lambs with a patent ductus arteriosus have higher plasma prostaglandin E2 concentrations than near-term newborn lambs with a contricted ductus arteriosus. To see whether these concentrations of PGE2 could produce patency of the ductus arteriosus, we studied eight near-term lambs (with constricted ductuses) delivered by cesarean section, paralyzed, and mechanically ventilated. After ductus arteriosus resistance and plasma PGE2 concentrations had stabilized, a continuous PGE2 infusion into the superior vena cava was started to determine threshold concentrations needed to dilate the ductus in vivo. By two hours after birth, circulating PGE2 concentrations in near-term lambs were considerably less then the threshold concentration, and the ductuses were constricted. In five premature newborn lambs, significantly lower concentrations of PGE2 were required to dilate the ductus: threshold and ED50 concentrations were one sixth and one third, respectively. In these premature lambs during the first two hours after birth, circulating PGE2 concentrations were twice as high as the calculated in vivo threshold level. Therefore, circulating PGE2 concentrations probably played a significant role in the patency of the ductus arteriosus in these premature lambs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854456     DOI: 10.1016/s0022-3476(83)80023-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel.

Authors:  M Tristani-Firouzi; H L Reeve; S Tolarova; E K Weir; S L Archer
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 2.  The pharmacological treatment of patent ductus arteriosus. A review of the evidence.

Authors:  R J Barst; W M Gersony
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

3.  Maturation of the contractile response of the Emu ductus arteriosus.

Authors:  Edward M Dzialowski; Henry Greyner
Journal:  J Comp Physiol B       Date:  2007-12-11       Impact factor: 2.200

4.  Developmental changes in the effects of prostaglandin E2 in the chicken ductus arteriosus.

Authors:  Pia Agren; Saskia van der Sterren; Angel L Cogolludo; Carlos E Blanco; Eduardo Villamor
Journal:  J Comp Physiol B       Date:  2008-08-26       Impact factor: 2.200

5.  Expression, activity, and function of phosphodiesterases in the mature and immature ductus arteriosus.

Authors:  Hanguan Liu; Vincent Manganiello; Nahid Waleh; Ronald I Clyman
Journal:  Pediatr Res       Date:  2008-11       Impact factor: 3.756

Review 6.  Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?

Authors:  P Vali; S Lakshminrusimha; A Pelech; M Underwood; F Ing
Journal:  J Perinatol       Date:  2019-09-27       Impact factor: 3.225

7.  A high ductal flow velocity is associated with successful pharmacological closure of patent ductus arteriosus in infants 22-27 weeks gestational age.

Authors:  Karl Wilhelm Olsson; Anders Jonzon; Richard Sindelar
Journal:  Crit Care Res Pract       Date:  2012-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.